骨肉瘤“冷转热”的概念蓝图:从肿瘤微环境分层假说到适应性治疗前景 A conceptual blueprint for "turning cold to hot" in Osteosarcoma: from TME stratification hypotheses to adaptive therapeutic prospects. PubMed 2026/04/15 发表Cell Commun SignalQ1 · IF 11.6(JCR 2025) 靶点:GD2技术:CAR-T技术:NK 细胞技术:外泌体骨肉瘤地区:中国
递送载荷的工程化γδ T 细胞在骨肉瘤临床前模型中显示出增强的细胞毒性、持久性和疗效 Payload-delivering engineered γδ T cells display enhanced cytotoxicity, persistence, and efficacy in preclinical models of osteosarcoma. PubMed 2024/05/29 发表Sci Transl MedQ1 · IF 15.6(JCR 2025) 靶点:GD2技术:NK 细胞技术:γδ T 细胞骨肉瘤地区:欧洲
一种通过 PET 和[(64)Cu]Cu-NOTA-ch14.18/CHO 指导儿童肿瘤 GD2 靶向治疗的新方法 A novel approach to guide GD2-targeted therapy in pediatric tumors by PET and [(64)Cu]Cu-NOTA-ch14.18/CHO. PubMed 2024/01/20 发表TheranosticsQ1 · IF 14.9(JCR 2025) 人群:儿童靶点:GD2技术:NK 细胞技术:NKT 细胞神经母细胞瘤骨肉瘤